Clinical trial

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

NCT02945176

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention ARGOS-IO system Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-03-01

PhaseNA

Conditions

Graft vs Host Diseaseverified · MONDO: graft versus host disease

Congenital Aniridiaunresolved

Chemical Burnsunresolved

Stevens-Johnson Syndromeverified · MONDO: Stevens-Johnson syndrome

Congenital Glaucomaverified · MONDO: congenital glaucoma

Interventions

ARGOS-IO systemDEVICE

Sponsors & collaborators

Implandata Ophthalmic Products GmbHlead sponsor

Mapped research locations

CologneGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02945176 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.